Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Live Q&A: Real-world Tactics to Address Health Inequities in Melanoma Care

Premiere Date: Thursday, November 17, 2022

This activity offers CE credit for:

1. Medicine (accme)
2. Nursing (ANCC)
3. Pharmacy (acpe)
4. PA (aapa)
5. Dietetic Registration (CDR)
6. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Friday, November 17, 2023
Note: Credit Is No Longer Available

Faculty

Edith Peterson Mitchell, MD, MACP, FCPP, FRCP (Moderator) Clinical Professor of Medicine and Medical Oncology Department of Medical Oncology Director, Center to Eliminate Cancer Disparities Associate Director, Diversity Affairs Sidney Kimmel Cancer Center at Jefferson Philadelphia, PA 116th President of the National Medical Association

Susan C. Taylor, MD, FAAD  Bernett L. Johnson Endowed Professor of Dermatology Vice Chair for Diversity, Equity and Inclusion Department of Dermatology Perelman School of Medicine University of Pennsylvania Founder of the Skin of Color Society Philadelphia, PA

Statement of Need

Where the predominance of melanoma is seen in White people, roughly 20 times that of Black people, the weight of later stage presentation, delayed treatment, and poorer outcomes falls on those of racial and ethnic underserved populations. A culmination of biases, disparities, and inequities continues a cycle of inadequate oncology treatment for melanoma, thus resulting in delayed diagnosis and suboptimal clinical management, prognosis, and survival rate.

This live Q&A session is your opportunity to ask questions based on the CME Outfitters BriefCase that focused on racial and ethnic disparities and health inequities in melanoma. To view the full activity ahead of this live Q&A, click here.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Recognize the impact of health inequities on patients with melanoma when crafting individual treatment strategies for optimal outcomes.

Financial Support

Supported by an educational grant from the Johnson & Johnson Institute and the Johnson & Johnson Family of Companies.

Target Audience

Physicians, PAs, NPs, nurses/nurse navigators, pharmacists, and dietitians specializing in oncology, pathology, radiology, dermatology, and primary care.

Credit Information

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 0.5 contact hours.

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Mitchell reports the following financial relationships:

Advisory Board: Corvus Pharmaceuticals, Inc.

Consultant: Amgen Inc.; Astellas Pharma Inc.; Bristol Myers Squibb; Genentech, Inc.; and SEMA4 OpCo, Inc.

Dr. Taylor reports the following financial relationships:

Advisory Board: AbbVie Inc.; Beiersdorf; Biorez; Galderma Laboratories, L.P.; GloGetter; Hugel America, Inc.; Janssen Pharmaceuticals, Inc.; L'Oreal USA; Medscape; Scientis SA; and UCB, Inc.

Consultant: Arcutis Biotherapeutics; Armis Biopharma; Beiersdorf; Cara Therapeutics; EPI Health; Evolus, Inc.; Johnson & Johnson; Piction Health; and Vichy Laboratories

Grants: Pfizer Inc.

Research Support: Concert Pharmaceuticals; Croma-Pharma GmbH; and Eli Lilly and Company

Speakers Bureau: BureauBeiersdorf; Evolus, Inc.; L'Oreal USA; Medscape; and MJH Life Sciences

Stock Shareholder (stock options): Armis Biopharma; GloGetter; and Piction Health

Other Financial or Material Support: McGraw Hill (book royalties) and Mercer Strategies (Board of Directors)

The following peer reviewer and CME Outfitters staff have no financial relationships:

Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer)

Meghann Taft-Lockard (planning committee)

David Modrak, PhD (planning committee)

Sandra Caballero, PharmD (planning committee)

Susan H. Yarbrough, CHCP (planning committee)

Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).